Home ›

2012

Zamora-Ros R, Not C, Guinó E, Luján-Barroso L, García RM, Biondo S, et al. Association between habitual dietary flavonoid and lignan intake and colorectal cancer in a Spanish case-control study (the Bellvitge Colorectal Cancer Study). Cancer causes & control : CCC. 2012. Abstract
Pubmed ID 22588680
Sala N, Muñoz X, Travier N, Agudo A, Duell EJ, Moreno V, et al. Prostate stem-cell antigen gene is associated with diffuse and intestinal gastric cancer in Caucasians: Results from the EPIC-EURGAST study. International journal of cancer. Journal international du cancer. 2012;130(10):2417-27. Abstract
Pubmed ID 21681742
Milà N, García M, Binefa G, Borràs JM, Espinàs JA, Moreno V. Adherence to a population-based colorectal cancer screening program in Catalonia (Spain), 2000-2008 . Gaceta sanitaria / S.E.S.P.A.S. 2012;26(3):217-22. Abstract
Pubmed ID 22361637
Campa D, Martino A, Sainz J, Buda G, Jamroziak K, Weinhold N, et al. Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium. British journal of haematology. 2012;157(3):331-8. Abstract
Pubmed ID 22590720
Barderas R, Babel I, Díaz-Uriarte R, Moreno V, Suárez A, Bonilla F, et al. An optimized predictor panel for colorectal cancer diagnosis based on the combination of tumor-associated antigens obtained from protein and phage microarrays. Journal of proteomics. 2012. Abstract
Pubmed ID 22465712
Crous-Bou M, Rennert G, Salazar R, Rodriguez-Moranta F, Rennert HS, Lejbkowicz F, et al. Genetic polymorphisms in fatty acid metabolism genes and colorectal cancer. Mutagenesis. 2012;27(2):169-76. Abstract
Pubmed ID 22294764
Houlston RS, members of CO, Moreno V. COGENT (COlorectal cancer GENeTics) revisited. Mutagenesis. 2012;27(2):143-51. Abstract
Pubmed ID <p>22294761</p>
Giráldez MD, López-Dóriga A, Bujanda L, Abulí A, Bessa X, Fernández-Rozadilla C, et al. Susceptibility genetic variants associated with early-onset colorectal cancer. Carcinogenesis. 2012;33(3):613-9. Abstract
Pubmed ID 22235025
Martino A, Sainz J, Buda G, Jamroziak K, Reis RM, García-Sanz R, et al. Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review). International journal of oncology. 2012;40(3):625-38. Abstract
Pubmed ID 22159523
Tian S, Simon I, Moreno V, Roepman P, Tabernero J, Snel M, et al. A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction. Gut. 2012. Abstract
Pubmed ID 22798500